Paper39149579
A Multimodal Preclinical Assessment of MDMA in Female and Male Rats: Prohedonic, Cognition Disruptive, and Prosocial Effects.
Adam AS and 4 others. Psychedelic Med (New Rochelle), 2024. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. A Multimodal Preclinical Assessment of MDMA in Female and Male Rats: Prohedonic, Cognition Disruptive, and Prosocial Effects. Papers, record 39149579. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39149579
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A Multimodal Preclinical Assessment of MDMA in Female and Male Rats: Prohedonic, Cognition Disruptive, and Prosocial Effects.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 DA048150 | NIDA NIH HHS | United States | R01DA048150 | PubMed |
Source NIH RePORTER
References80
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15705346 | Toward an objective characterization of an anhedonic phenotype: a signal-detection approach. | Biol Psychiatry | 2005 | https://conductscience.org/library/papers/15705346 | PubMed |
| 2 | 34921225 | A cross-species assay demonstrates that reward responsiveness is enduringly impacted by adverse, unpredictable early-life experiences. | Neuropsychopharmacology | 2022 | https://conductscience.org/library/papers/34921225 | PubMed |
| 3 | 18726908 | Single dose of a dopamine agonist impairs reinforcement learning in humans: evidence from event-related potentials and computational modeling of striatal-cortical function. | Hum Brain Mapp | 2009 | https://conductscience.org/library/papers/18726908 | PubMed |
| 4 | 35341568 | Examining the effects of psychoactive drugs on complex behavioral processes in laboratory animals. | Adv Pharmacol | 2022 | https://conductscience.org/library/papers/35341568 | PubMed |
| 5 | 35040425 | Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review - CORRIGENDUM. | BJPsych Open | 2022 | https://conductscience.org/library/papers/35040425 | PubMed |
| 6 | 16508761 | Acute dose of MDMA (75 mg) impairs spatial memory for location but leaves contextual processing of visuospatial information unaffected. | Psychopharmacology (Berl) | 2007 | https://conductscience.org/library/papers/16508761 | PubMed |
| 7 | 33852780 | Trial of Psilocybin versus Escitalopram for Depression. | N Engl J Med | 2021 | https://conductscience.org/library/papers/33852780 | PubMed |
| 8 | 21289169 | Dopamine-mediated reinforcement learning signals in the striatum and ventromedial prefrontal cortex underlie value-based choices. | J Neurosci | 2011 | https://conductscience.org/library/papers/21289169 | PubMed |
| 9 | 33146667 | Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. | JAMA Psychiatry | 2021 | https://conductscience.org/library/papers/33146667 | PubMed |
| 10 | 27909165 | Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. | J Psychopharmacol | 2016 | https://conductscience.org/library/papers/27909165 | PubMed |
| 11 | 32777649 | Neurocognitive impact of ketamine treatment in major depressive disorder: A review on human and animal studies. | J Affect Disord | 2020 | https://conductscience.org/library/papers/32777649 | PubMed |
| 12 | 33280005 | Translational Assessments of Reward Responsiveness in the Marmoset. | Int J Neuropsychopharmacol | 2021 | https://conductscience.org/library/papers/33280005 | PubMed |
| 13 | 32792526 | Empirical validation of a touchscreen probabilistic reward task in rats. | Transl Psychiatry | 2020 | https://conductscience.org/library/papers/32792526 | PubMed |
| 14 | 32871534 | Neurocognitive performance of repeated versus single intravenous subanesthetic ketamine in treatment resistant depression. | J Affect Disord | 2020 | https://conductscience.org/library/papers/32871534 | PubMed |
| 15 | 34727422 | Effects of Ketamine Versus Midazolam on Neurocognition at 24 Hours in Depressed Patients With Suicidal Ideation. | J Clin Psychiatry | 2021 | https://conductscience.org/library/papers/34727422 | PubMed |
| 16 | 19373443 | Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. | Mol Neurobiol | 2009 | https://conductscience.org/library/papers/19373443 | PubMed |
| 17 | 21279163 | Titrating-delay matching-to-sample in the pigeon. | J Exp Anal Behav | 2010 | https://conductscience.org/library/papers/21279163 | PubMed |
| 18 | 18520604 | Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults. | Ther Drug Monit | 2008 | https://conductscience.org/library/papers/18520604 | PubMed |
| 19 | 33711169 | Methylenedioxymethamphetamine (MDMA): Serotonergic and dopaminergic mechanisms related to its use and misuse. | J Neurochem | 2021 | https://conductscience.org/library/papers/33711169 | PubMed |
| 20 | 25374095 | Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial. | Neuropsychopharmacology | 2015 | https://conductscience.org/library/papers/25374095 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41354763 | ENX-104: a selective and potent D2/D3 receptor antagonist enhances dopamine neurotransmission and reward responsiveness in translational rodent models. | Neuropsychopharmacology | 2026 | https://conductscience.org/library/papers/41354763 | PubMed |
| 41121647 | History, pharmacology and therapeutic mechanisms of 3,4-methylenedioxymethamphetamine (MDMA). | Br J Pharmacol | 2026 | https://conductscience.org/library/papers/41121647 | PubMed |
| 40288209 | Environmental determinants of ketamine's prohedonic and antianhedonic efficacy: Persistence of enhanced reward responsiveness is modulated by chronic stress. | J Pharmacol Exp Ther | 2025 | https://conductscience.org/library/papers/40288209 | PubMed |
| 39068642 | Methylenedioxymethamphetamine is a connectogen with empathogenic, entactogenic, and still further connective properties: It is time to reconcile "the great entactogen-empathogen debate". | J Psychopharmacol | 2024 | https://conductscience.org/library/papers/39068642 | PubMed |
| 38922872 | Chronic ecologically relevant stress effects on reverse-translated touchscreen assays of reward responsivity and attentional processes in male rats: Implications for depression. | J Neurochem | 2024 | https://conductscience.org/library/papers/38922872 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39149579
GET https://conductscience.org/api/papers/v1/39149579/references?page=2